Novo Nordisk Agrees

NJ 2010 Independent Pharmacies

OIG False Claims

Penalty

$58.6 million

Outcome

OIG enforcement action against Novo Nordisk Agrees for false claims. Penalty: $58.6 million.

Details

Novo Nordisk Agrees — OIG Enforcement (2010)

OIG took enforcement action against Novo Nordisk Agrees in NJ in 2010 involving false claims violations in the Independent Pharmacies sector.

Penalty: $58.6 million

Violation types: False Claims
Entity type: Pharmacy
Penalty type: Settlement
Location: NJ

Source: Novo Nordisk Agrees to Pay $58 Million for Failure to Comply with FDA-Mandated Risk Program

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery.

Source: Novo Nordisk Agrees to Pay $58 Million for Failure to Comply with FDA-Mandated Risk Program

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works